Objective: Abdominal aortic aneurysms (AAAs) are highly lethal diseases without effective
clinical predictors and therapeutic targets. Vascular microcalcification, as detected by …

Abdominal aortic aneurysm (AAA) is a common inflammatory vascular disease. Angiotensin
II (Ang II) involves in AAA progression by promoting the proliferation and migration of …

Targeted drug delivery (TDD) to abdominal aortic aneurysm (AAA) using a controlled and
efficient approach has recently been a significant challenge. In this study, by using magnetic …

In addition to maintaining immune tolerance, Foxp3+ regulatory T cells (Tregs) perform
specialized functions in tissue homeostasis and remodeling. However, whether Tregs in …

Introduction: Abdominal aortic aneurysm (AAA) is a common, complex, and life-threatening
disease. Currently, the pathogenesis of AAA is not well understood. No biomarkers or …

Objective Observational studies demonstrate an inverse association between type II
diabetes and abdominal aortic aneurysm (AAA) for reasons that are unclear. The aim of this …

Abdominal aortic aneurysms (AAAs) have posed a great threat to human life, and the
necessity of its monitoring and treatment is decided by symptomatology and/or the aneurysm …

Objective There is no medical treatment proven to limit abdominal aortic aneurysm (AAA)
progression. This systematic review aimed to summarise available trial evidence on the …

No drug therapy has shown to limit abdominal aortic aneurysm (AAA) growth or rupture, and
the understanding of the disease biology is incomplete; whereby, one challenge of vascular …

Background: Abdominal aortic aneurysm (AAA) is a life-threatening cardiovascular disease
characterized by dilated abdominal aorta. Immune cells have been shown to contribute to …